Albumedix, Cobra partner on viral vector manufacturing

By The Science Advisory Board staff writers

April 28, 2021 -- Albumedix and Cobra Biologics, the gene therapy division of Cognate BioServices, will collaborate on viral vector manufacturing.

The companies will focus on upstream and downstream process optimization and stability enhancement in scale-up manufacturing of adeno-associated viruses and lentiviral vectors through proprietary recombinant human albumin-based product from Albumedix.

Financial details of the collaboration were not disclosed.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.